HB-302/HB-301 Therapy in Participants With Metastatic Castration-Resistant Prostate Cancer

Clinical trial NCT05553639 · TERMINATED

Trial details

NCT number: NCT05553639
Sponsor: Hookipa Biotech GmbH
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Prostate Cancer Metastatic

Start date: 2023-05-23
Primary completion: 2024-04-29
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.